KLEPTOSE® HPB

Push back your formulation limits with HPBCD enabling technology

You will be aware that cyclodextrin’s ability to form inclusion compounds through molecular encapsulation makes it of great interest as a formulation aid.

Several pharmaceutical products on the market use this cyclodextrin technology for which Roquette has been producing and supplying the enabling excipient:
KLEPTOSE^® HPB (hydroxypropyl-beta-cyclodextrin-HPBCD).

KLEPTOSE^® HPB excipient grade is suitable for syrups and oral suspensions, as well as for dry formulations.
KLEPTOSE^® HPB pyrogen-free grade is suitable for parenteral formulations.

For a long time this HPBCD technology has been used exclusively by a selected few. Today, the patent environment for HPBCD is more favorable for new formulations and the use of HPBCD technology in pharmaceuticals is now free of any broad-use restrictions except on US territory.

You no longer have to let a poorly soluble active ingredient limit your formulation power!

or simply ask for our KLEPTOSE^® technical brochures

and/or a sample.

Alternatively, call your local representative.

Roquette Pharma is a global manufacturer and supplier of pharmaceutical excipients, actives and cosmetics ingredients, providing also services and formulation assistance. Roquette's pharma specialities are ideally suited for pharmaceutical and drug formulations : oral dosage forms such as tablets, capsules, paste products including tooth paste, injectable solutions, clinical nutrition and nutraceutical products, liquid and confectionery forms.